These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 23588203)

  • 101. Prevention of tumor risk associated with the reprogramming of human pluripotent stem cells.
    Wuputra K; Ku CC; Wu DC; Lin YC; Saito S; Yokoyama KK
    J Exp Clin Cancer Res; 2020 Jun; 39(1):100. PubMed ID: 32493501
    [TBL] [Abstract][Full Text] [Related]  

  • 102. Ubiquitin-specific protease 3 promotes cell migration and invasion by interacting with and deubiquitinating SUZ12 in gastric cancer.
    Wu X; Liu M; Zhu H; Wang J; Dai W; Li J; Zhu D; Tang W; Xiao Y; Lin J; Zhang W; Sun Y; Zhang Y; Chen Y; Li G; Li A; Xiang L; Liu S; Wang J
    J Exp Clin Cancer Res; 2019 Jun; 38(1):277. PubMed ID: 31234902
    [TBL] [Abstract][Full Text] [Related]  

  • 103. Blockade of enhancer of zeste homolog 2 alleviates renal injury associated with hyperuricemia.
    Shi Y; Xu L; Tao M; Fang L; Lu J; Gu H; Ma S; Lin T; Wang Y; Bao W; Qiu A; Zhuang S; Liu N
    Am J Physiol Renal Physiol; 2019 Mar; 316(3):F488-F505. PubMed ID: 30566000
    [TBL] [Abstract][Full Text] [Related]  

  • 104. Soft Tissue Sarcoma Cancer Stem Cells: An Overview.
    Genadry KC; Pietrobono S; Rota R; Linardic CM
    Front Oncol; 2018; 8():475. PubMed ID: 30416982
    [TBL] [Abstract][Full Text] [Related]  

  • 105. Targeting histone methylation for colorectal cancer.
    Huang T; Lin C; Zhong LL; Zhao L; Zhang G; Lu A; Wu J; Bian Z
    Therap Adv Gastroenterol; 2017 Jan; 10(1):114-131. PubMed ID: 28286564
    [TBL] [Abstract][Full Text] [Related]  

  • 106. Cancer stem cell heterogeneity: origin and new perspectives on CSC targeting.
    Eun K; Ham SW; Kim H
    BMB Rep; 2017 Mar; 50(3):117-125. PubMed ID: 27998397
    [TBL] [Abstract][Full Text] [Related]  

  • 107. miR-564 acts as a dual inhibitor of PI3K and MAPK signaling networks and inhibits proliferation and invasion in breast cancer.
    Mutlu M; Saatci Ö; Ansari SA; Yurdusev E; Shehwana H; Konu Ö; Raza U; Şahin Ö
    Sci Rep; 2016 Sep; 6():32541. PubMed ID: 27600857
    [TBL] [Abstract][Full Text] [Related]  

  • 108. Cancer Stem Cells: Dynamic Entities in an Ever-Evolving Paradigm.
    Lopez-Bertoni H; Li Y; Laterra J
    Biol Med (Aligarh); 2015 Nov; 7(Suppl 2):. PubMed ID: 27158195
    [TBL] [Abstract][Full Text] [Related]  

  • 109. Epigenetics in Intestinal Epithelial Cell Renewal.
    Roostaee A; Benoit YD; Boudjadi S; Beaulieu JF
    J Cell Physiol; 2016 Nov; 231(11):2361-7. PubMed ID: 27061836
    [TBL] [Abstract][Full Text] [Related]  

  • 110. Role of NADH Dehydrogenase (Ubiquinone) 1 Alpha Subcomplex 4-Like 2 in Clear Cell Renal Cell Carcinoma.
    Minton DR; Fu L; Mongan NP; Shevchuk MM; Nanus DM; Gudas LJ
    Clin Cancer Res; 2016 Jun; 22(11):2791-801. PubMed ID: 26783287
    [TBL] [Abstract][Full Text] [Related]  

  • 111. Enhancer of Zeste Homolog 2 Inhibition Attenuates Renal Fibrosis by Maintaining Smad7 and Phosphatase and Tensin Homolog Expression.
    Zhou X; Zang X; Ponnusamy M; Masucci MV; Tolbert E; Gong R; Zhao TC; Liu N; Bayliss G; Dworkin LD; Zhuang S
    J Am Soc Nephrol; 2016 Jul; 27(7):2092-108. PubMed ID: 26701983
    [TBL] [Abstract][Full Text] [Related]  

  • 112. DZNep inhibits the proliferation of colon cancer HCT116 cells by inducing senescence and apoptosis.
    Sha M; Mao G; Wang G; Chen Y; Wu X; Wang Z
    Acta Pharm Sin B; 2015 May; 5(3):188-93. PubMed ID: 26579445
    [TBL] [Abstract][Full Text] [Related]  

  • 113. Common stemness regulators of embryonic and cancer stem cells.
    Hadjimichael C; Chanoumidou K; Papadopoulou N; Arampatzi P; Papamatheakis J; Kretsovali A
    World J Stem Cells; 2015 Oct; 7(9):1150-84. PubMed ID: 26516408
    [TBL] [Abstract][Full Text] [Related]  

  • 114. Wedelolactone disrupts the interaction of EZH2-EED complex and inhibits PRC2-dependent cancer.
    Chen H; Gao S; Li J; Liu D; Sheng C; Yao C; Jiang W; Wu J; Chen S; Huang W
    Oncotarget; 2015 May; 6(15):13049-59. PubMed ID: 25944687
    [TBL] [Abstract][Full Text] [Related]  

  • 115. Down-regulation of miR-489 contributes into NSCLC cell invasion through targeting SUZ12.
    Xie Z; Cai L; Li R; Zheng J; Wu H; Yang X; Li H; Wang Z
    Tumour Biol; 2015 Aug; 36(8):6497-505. PubMed ID: 25833694
    [TBL] [Abstract][Full Text] [Related]  

  • 116. EZH2 inhibition enhances the efficacy of an EGFR inhibitor in suppressing colon cancer cells.
    Katona BW; Liu Y; Ma A; Jin J; Hua X
    Cancer Biol Ther; 2014; 15(12):1677-87. PubMed ID: 25535899
    [TBL] [Abstract][Full Text] [Related]  

  • 117. Prognostic value of polycomb proteins EZH2, BMI1 and SUZ12 and histone modification H3K27me3 in colorectal cancer.
    Benard A; Goossens-Beumer IJ; van Hoesel AQ; Horati H; Putter H; Zeestraten EC; van de Velde CJ; Kuppen PJ
    PLoS One; 2014; 9(9):e108265. PubMed ID: 25243792
    [TBL] [Abstract][Full Text] [Related]  

  • 118. The impact of microRNA-mediated PI3K/AKT signaling on epithelial-mesenchymal transition and cancer stemness in endometrial cancer.
    Dong P; Konno Y; Watari H; Hosaka M; Noguchi M; Sakuragi N
    J Transl Med; 2014 Aug; 12():231. PubMed ID: 25141911
    [TBL] [Abstract][Full Text] [Related]  

  • 119. The roles of retinoic acid and retinoic acid receptors in inducing epigenetic changes.
    Urvalek A; Laursen KB; Gudas LJ
    Subcell Biochem; 2014; 70():129-49. PubMed ID: 24962884
    [TBL] [Abstract][Full Text] [Related]  

  • 120. Pharmacological inhibition of EZH2 as a promising differentiation therapy in embryonal RMS.
    Ciarapica R; Carcarino E; Adesso L; De Salvo M; Bracaglia G; Leoncini PP; Dall'agnese A; Verginelli F; Milano GM; Boldrini R; Inserra A; Stifani S; Screpanti I; Marquez VE; Valente S; Mai A; Puri PL; Locatelli F; Palacios D; Rota R
    BMC Cancer; 2014 Feb; 14():139. PubMed ID: 24575771
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.